389
Views
1
CrossRef citations to date
0
Altmetric
Expert Opinion

Burden of Disease, Unmet Needs in the Diagnosis and Management of Atopic Dermatitis: An Indian Expert Consensus

, , , , , , , , ORCID Icon, , & show all
Pages 1755-1765 | Published online: 22 Nov 2021

References

  • Weidinger S, Beck LA, Bieber T, Kabashima K, Irvine AD. Atopic dermatitis. Nat Rev Dis Prim. 2018;4(1). doi:10.1038/s41572-018-0001-z
  • Nettis E, Ortoncelli M, Pellacani G, et al. A multicenter study on the prevalence of clinical patterns and clinical phenotypes in adult atopic dermatitis. J Investig Allergol Clin Immunol. 2020;30(6):448–472. doi:10.18176/jiaci.0519
  • Silverberg JI, Vakharia PP, Chopra R, et al. Phenotypical differences of childhood- and adult-onset atopic dermatitis. J Allergy Clin Immunol Pract. 2018;6(4):1306–1312. doi:10.1016/j.jaip.2017.10.005
  • Ozkaya E. Adult-onset atopic dermatitis. J Am Acad Dermatol. 2005;52(4):579–582. doi:10.1016/j.jaad.2004.11.037
  • Lifschitz C. The impact of atopic dermatitis on quality of life. Ann Nutr Metab. 2015;66(suppl 1):34–40. doi:10.1159/000370226
  • Blome C, Radtke MA, Eissing L, Augustin M. Quality of life in patients with atopic dermatitis: disease burden, measurement, and treatment benefit. Am J Clin Dermatol. 2016;17(2):163–169. doi:10.1007/s40257-015-0171-3
  • Chiesa Fuxench ZC. Atopic dermatitis: disease background and risk factors. Adv Exp Med Biol. 2017;1027:11–19. doi:10.1007/978-3-319-64804-0_2
  • Barbarot S, Auziere S, Gadkari A, et al. Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy Eur J Allergy Clin Immunol. 2018;73(6):1284–1293. doi:10.1111/all.13401
  • Hay RJ, Johns NE, Williams HC, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134(6):1527–1534. doi:10.1038/jid.2013.446
  • Laughter MR, Maymone MBC, Mashayekhi S, et al. The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990–2017*. Br J Dermatol. 2021;184(2):304–309. doi:10.1111/bjd.19580
  • Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI; ISAAC Phase Three Study Group. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol. 2009;124(6):1251–1258.e23. doi:10.1016/j.jaci.2009.10.009
  • Kumar MK, Singh PK, Tahir MMA. The clinico-epidemiological profile and the risk factors associated with the severity of atopic dermatitis (AD) in eastern Indian children. J Clin Diagnostic Res. 2012;6(7 SUPPL):1162–1166.
  • Sehgal V, Srivastava G, Aggarwal A, Saxena D, Chatterjee K, Khurana A. Atopic dermatitis: a cross-sectional (descriptive) study of 100 cases. Indian J Dermatol. 2015;60(5):519. doi:10.4103/0019-5154.164412
  • Jawade SA, Chugh VS, Gohil SK, Mistry AS, Umrigar DD. A clinico-etiological study of dermatoses in pediatric age group in tertiary health care center in South Gujarat region. Indian J Dermatol. 2015;60(6):635. doi:10.4103/0019-5154.169147
  • Upendra Y, Keswani N, Sendur S, Pallava A. The clinico-epidemiological profile of atopic dermatitis in residential school children: a study from South Chhattisgarh, India. Indian J Paediatr Dermatol. 2017;18(4):281. doi:10.4103/ijpd.ijpd_52_17
  • Tsai TF, Rajagopalan M, Chu CY, et al. Burden of atopic dermatitis in Asia. J Dermatol. 2019;46(10):825–834. doi:10.1111/1346-8138.15048
  • Kanwar A, De D. Epidemiology and clinical features of atopic dermatitis in India. Indian J Dermatol. 2011;56(5):471. doi:10.4103/0019-5154.87112
  • Senra MS, Wollenberg A. Psychodermatological aspects of atopic dermatitis. Br J Dermatol. 2014;170(SUPPL. 1):38–43. doi:10.1111/bjd.13084
  • Handa S, Jain N, Narang T. Cost of care of atopic dermatitis in India. Indian J Dermatol. 2015;60(2):213. doi:10.4103/0019-5154.152573
  • Rajagopalan M, De A, Godse K, et al. Guidelines on management of atopic dermatitis in India: an evidence-based review and an expert consensus. Indian J Dermatol. 2019;64(3):166. doi:10.4103/ijd.IJD_683_18
  • Sathishkumar D, Gupta A, Saini K. Atopic dermatitis in children: an update for pediatricians. Curr Med Issues. 2020;18(4):317. doi:10.4103/cmi.cmi_81_20
  • Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis Work Group. J Am Acad Dermatol. 2014;70(2):338–351. doi:10.1016/j.jaad.2013.10.010
  • Vakharia PP, Chopra R, Silverberg JI. Systematic review of diagnostic criteria used in atopic dermatitis randomized controlled trials. Am J Clin Dermatol. 2018;19(1):15–22. doi:10.1007/s40257-017-0299-4
  • Silvestre Salvador J, Romero-Pérez D, Encabo-Durán B. Atopic dermatitis in adults: a diagnostic challenge. J Investig Allergol Clin Immunol. 2017;27(2):78–88. doi:10.18176/jiaci.0138
  • Sinclair W, Aboobaker J, Green RJ, Levin ME. Diagnosis of atopic dermatitis: from bedside to laboratory. South African Med J. 2014;104(10):711. doi:10.7196/SAMJ.8850
  • Kim JP, Chao LX, Simpson EL, Silverberg JI. Persistence of atopic dermatitis (AD): a systematic review and meta-analysis. J Am Acad Dermatol. 2016;75(4):681–687.e11. doi:10.1016/j.jaad.2016.05.028
  • Dhar S, Bisweswar Mandal AG. Epidemiology and clinical pattern of atopic dermatitis in 100 children seen in a city hospital. Indian J Dermatol. 2002;47(4):202–204.
  • Yang G, Seok JK, Kang HC, Cho YY, Lee HS, Lee JY. Skin barrier abnormalities and immune dysfunction in atopic dermatitis. Int J Mol Sci. 2020;21(8):1–14. doi:10.3390/ijms21082867
  • Magnifico I, Petronio GP, Venditti N, et al. Atopic dermatitis as a multifactorial skin disorder. Can the analysis of pathophysiological targets represent the winning therapeutic strategy? Pharmaceuticals. 2020;13(11):1–18. doi:10.3390/ph13110411
  • Totte JEE, van der Feltz WT, Hennekam M, van Belkum A, van Zuuren EJ, Pasmans SGMA. Prevalence and odds of S taphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis. Br J Dermatol. 2016;175(4):687–695. doi:10.1111/bjd.14566
  • Kurien G, Divakaran MV, Sadanandan SM, Sobhanakumari K, Sarin A, Jagadeesan S. Methicillin-resistant Staphylococcus aureus colonization and disease severity in atopic dermatitis: a cross-sectional study from South India. Indian J Dermatol, Venereol Leprol. 2014;80(3):229–234. doi:10.4103/0378-6323.132250
  • Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020;396(10247):345–360. doi:10.1016/S0140-6736(20)31286-1
  • LeBovidge JS, Elverson W, Timmons KG, et al. Multidisciplinary interventions in the management of atopic dermatitis. J Allergy Clin Immunol. 2016;138(2):325–334. doi:10.1016/j.jaci.2016.04.003
  • Frazier W, Bhardwaj N. Atopic dermatitis: diagnosis and treatment. Am Fam Physician. 2020;101(10):590–598.
  • Nankervis H, Thomas KS, Delamere FM, Barbarot S, Rogers NK, Williams HC. Scoping systematic review of treatments for eczema. Program Grants Appl Res. 2016;4(7):1–480. doi:10.3310/pgfar04070
  • Green C, Colquitt JL, Kirby J, Davidson P. Topical corticosteroids for atopic eczema: clinical and cost effectiveness of once-daily vs. more frequent use. Br J Dermatol. 2005;152(1):130–141. doi:10.1111/j.1365-2133.2005.06410.x
  • Berke R, Singh A, Guralnick M. Atopic dermatitis: an overview. Am Fam Physician. 2012;86(1):35–42.
  • Drucker AM, Eyerich K, de Bruin-Weller MS, et al. Use of systemic corticosteroids for atopic dermatitis: international Eczema Council consensus statement. Br J Dermatol. 2018;178(3):768–775. doi:10.1111/bjd.15928
  • Yu SH, Drucker AM, Lebwohl M, Silverberg JI. A systematic review of the safety and efficacy of systemic corticosteroids in atopic dermatitis. J Am Acad Dermatol. 2018;78(4):733–740.e11. doi:10.1016/j.jaad.2017.09.074
  • Sidbury R, Davis DM, Cohen DE, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71(2):327–349. doi:10.1016/j.jaad.2014.03.030
  • Garritsen FM, Brouwer MWD, Limpens J, Spuls PI. Photo(chemo)therapy in the management of atopic dermatitis: an updated systematic review with implications for practice and research. Br J Dermatol. 2014;170(3):501–513. doi:10.1111/bjd.12645
  • Rashmi Sarkar AJK. Clinico-epidemiological profile and factors affecting severity of atopic dermatitis in north Indian children. Indian J Dermatol. 2004;49(3):117–122.
  • Karthikeyan K, Thappa DM, Jeevankumar B. Pattern of pediatric dermatoses in a referral center in South India. Indian Pediatr. 2004;41(4):373–377.
  • Handa S, Khullar G, Pal A, Kamboj P, De D. Filaggrin gene mutations in hand eczema patients in the Indian subcontinent: a prospective case-control study. Contact Dermatitis. 2019;80(6):359–364. doi:10.1111/cod.13233
  • Jain C, Das S, Ramachandran VG, Saha R, Bhattacharya SN, Dar S. Malassezia yeast and cytokine gene polymorphism in atopic dermatitis. J Clin Diagnostic Res. 2017;11(3):DC01–DC05. doi:10.7860/JCDR/2017/23948.9474
  • Dhar S, Kanwar AJ. Epidemiology and clinical pattern of atopic dermatitis in a north Indian pediatric population. Pediatr Dermatol. 1998;15(5):347–351. doi:10.1046/j.1525-1470.1998.1998015347.x
  • Kim JE, Kim HJ, Lew BL, et al. Consensus guidelines for the treatment of atopic dermatitis in Korea (part II): systemic treatment. Ann Dermatol. 2015;27(5):578–592. doi:10.5021/ad.2015.27.5.578
  • Fujii M. Current understanding of pathophysiological mechanisms of atopic dermatitis: interactions among skin barrier dysfunction, immune abnormalities and pruritus. Biol Pharm Bull. 2020;43(1):12–19. doi:10.1248/bpb.b19-00088